Free Trial

Natural Alternatives International (NAII) Competitors

Natural Alternatives International logo
$3.55 -0.04 (-1.11%)
As of 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

NAII vs. BYSI, PMVP, IGMS, ASRT, UNCY, IZTC, CNTX, RPTX, SLGL, and ELYM

Should you be buying Natural Alternatives International stock or one of its competitors? The main competitors of Natural Alternatives International include BeyondSpring (BYSI), PMV Pharmaceuticals (PMVP), IGM Biosciences (IGMS), Assertio (ASRT), Unicycive Therapeutics (UNCY), Invizyne Technologies (IZTC), Context Therapeutics (CNTX), Repare Therapeutics (RPTX), Sol-Gel Technologies (SLGL), and Eliem Therapeutics (ELYM). These companies are all part of the "pharmaceutical products" industry.

Natural Alternatives International vs. Its Competitors

BeyondSpring (NASDAQ:BYSI) and Natural Alternatives International (NASDAQ:NAII) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, media sentiment, dividends, analyst recommendations, profitability and earnings.

Natural Alternatives International has higher revenue and earnings than BeyondSpring.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BeyondSpringN/AN/A-$11.12MN/AN/A
Natural Alternatives International$113.80M0.19-$7.22M-$1.39-2.52

In the previous week, BeyondSpring and BeyondSpring both had 2 articles in the media. Natural Alternatives International's average media sentiment score of 1.46 beat BeyondSpring's score of 0.95 indicating that Natural Alternatives International is being referred to more favorably in the news media.

Company Overall Sentiment
BeyondSpring Positive
Natural Alternatives International Positive

BeyondSpring has a beta of 0.22, meaning that its stock price is 78% less volatile than the S&P 500. Comparatively, Natural Alternatives International has a beta of 0.57, meaning that its stock price is 43% less volatile than the S&P 500.

40.3% of BeyondSpring shares are held by institutional investors. Comparatively, 32.4% of Natural Alternatives International shares are held by institutional investors. 29.3% of BeyondSpring shares are held by insiders. Comparatively, 20.9% of Natural Alternatives International shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

BeyondSpring has a net margin of 0.00% compared to Natural Alternatives International's net margin of -6.56%. BeyondSpring's return on equity of 0.00% beat Natural Alternatives International's return on equity.

Company Net Margins Return on Equity Return on Assets
BeyondSpringN/A N/A N/A
Natural Alternatives International -6.56%-10.34%-5.19%

Summary

BeyondSpring beats Natural Alternatives International on 5 of the 9 factors compared between the two stocks.

Get Natural Alternatives International News Delivered to You Automatically

Sign up to receive the latest news and ratings for NAII and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NAII and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NAII vs. The Competition

MetricNatural Alternatives InternationalMED IndustryMedical SectorNASDAQ Exchange
Market Cap$22.18M$2.59B$5.86B$10.15B
Dividend YieldN/A56.51%5.68%4.59%
P/E Ratio-2.5223.5374.5225.93
Price / Sales0.19702.37540.10123.77
Price / CashN/A171.1637.5660.44
Price / Book0.265.3712.166.29
Net Income-$7.22M$32.95M$3.28B$270.77M
7 Day Performance-2.78%1.31%0.98%3.36%
1 Month Performance-7.77%8.31%7.20%6.41%
1 Year Performance-44.00%0.29%63.06%28.26%

Natural Alternatives International Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NAII
Natural Alternatives International
1.6504 of 5 stars
$3.50
-2.5%
N/A-43.7%$22.18M$113.80M-2.52290Positive News
Short Interest ↓
BYSI
BeyondSpring
N/A$1.99
+4.5%
N/A-13.4%$80.06M$1.75M0.0080Gap Down
PMVP
PMV Pharmaceuticals
2.8446 of 5 stars
$1.48
+5.4%
$5.50
+272.9%
-18.5%$77.90MN/A-0.9450News Coverage
Positive News
Insider Trade
High Trading Volume
IGMS
IGM Biosciences
4.0669 of 5 stars
$1.27
flat
$4.89
+285.0%
N/A$76.57M$145.05M-1.41190
ASRT
Assertio
1.7562 of 5 stars
$0.79
-1.5%
$2.38
+199.5%
-36.6%$76.32M$124.96M-1.7620
UNCY
Unicycive Therapeutics
2.1038 of 5 stars
$4.29
-1.9%
$60.00
+1,300.2%
+2.3%$75.69M$680K-1.049
IZTC
Invizyne Technologies
N/A$12.00
+0.3%
N/AN/A$75.02MN/A0.0029News Coverage
CNTX
Context Therapeutics
3.5152 of 5 stars
$0.84
+1.7%
$5.25
+528.7%
-60.9%$74.90MN/A-2.327News Coverage
Short Interest ↓
RPTX
Repare Therapeutics
2.8554 of 5 stars
$1.74
+1.8%
$4.50
+158.6%
-35.6%$74.75M$53.48M-0.67180Positive News
SLGL
Sol-Gel Technologies
0.7687 of 5 stars
$26.45
-4.0%
N/A+267.6%$73.80M$11.54M-21.5050Short Interest ↑
ELYM
Eliem Therapeutics
N/A$2.47
+3.3%
N/A-69.8%$73.49MN/A-4.669Gap Up

Related Companies and Tools


This page (NASDAQ:NAII) was last updated on 9/12/2025 by MarketBeat.com Staff
From Our Partners